| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 20, 2025 | CRL Charles River Laboratories International, Inc. | Laplume Joseph W66 | EVP, Corp Strategy &Develop | Sell | 4,400 | $162.50 | $715,000.00 | -18.0% | -16.8% | +4.1% | |
| Feb 20, 2025 | CSTL Castle Biosciences Inc | Stokes Frank70 | Chief Financial Officer | Sell | 8,046 | $26.70 | $214,828.20 | -18.6% | -38.7% | +11.7% | |
| Feb 20, 2025 | CRL Charles River Laboratories International, Inc. | Foster James C77 | Chairman, President And CEO | Buy | 6,075 | $165.01 | $1,002,435.75 | +3.4% | -16.8% | +4.1% | |
| Feb 20, 2025 | CRL Charles River Laboratories International, Inc. | Girshick Birgit65 | Corporate Executive VP &COO | Buy | 1,514 | $164.63 | $249,249.82 | +2.8% | -16.8% | +4.1% | |
| Feb 20, 2025 | GH Guardant Health, Inc. | Tariq Musa | Director | Sell | 116 | $48.33 | $5,606.28 | -3.6% | -21.8% | +117.5% | |
| Feb 19, 2025 | TMO Thermo Fisher Scientific Inc. | Chai Nelson46 | Director | Sell | 16 | $528.09 | $8,449.44 | -0.1% | -22.1% | -3.0% | |
| Feb 18, 2025 | NOTV Inotiv, Inc. | Freeman Jeffrey Brennan | Vp-finance &Corp. Controller | Sell | 1,339 | $4.05 | $5,416.26 | -4.6% | -41.4% | -92.3% | |
| Feb 18, 2025 | NOTV Inotiv, Inc. | Taylor Beth54 | Chief Financial Officer | Sell | 4,370 | $4.01 | $17,506.66 | -3.9% | -41.4% | -92.3% | |
| Feb 18, 2025 | NOTV Inotiv, Inc. | Sagartz John E60 | Chief Strategy Officer | Sell | 2,113 | $3.94 | $8,316.13 | -0.3% | -41.4% | -92.3% | |
| Feb 18, 2025 | NOTV Inotiv, Inc. | Leasure Robert Jr.63 | President And CEO | Sell | 73,617 | $3.82 | $281,135.96 | -7.1% | -41.4% | -92.3% | |
| Feb 11, 2025 | MTD Mettler Toledo International Inc/ | De La Guerroniere Marc56 | Head Of Eur &Na Market Orgs | Sell | 888 | $1,331.89 | $1,182,718.86 | -81.7% | -11.8% | +4.6% | |
| Feb 11, 2025 | BDSX Biodesix Inc | Pestano Gary Anthony65 | Chief Development Officer | Sell | 16,748 | $0.92 | $15,478.50 | -9.7% | -62.2% | -45.5% | |
| Feb 11, 2025 | BDSX Biodesix Inc | Cowie Robin Harper62 | CFO, Sec'y &Treasurer | Sell | 24,664 | $0.92 | $22,794.47 | -9.1% | -62.2% | -45.5% | |
| Feb 11, 2025 | BDSX Biodesix Inc | O'Kane Kieran64 | Chief Commercial Officer | Sell | 17,527 | $0.92 | $16,198.45 | -12.0% | -62.2% | -45.5% | |
| Feb 11, 2025 | BDSX Biodesix Inc | Vazquez Chris65 | Chief Accounting Officer | Sell | 3,630 | $0.92 | $3,354.85 | -17.1% | -62.2% | -45.5% | |
| Feb 11, 2025 | BDSX Biodesix Inc | Hutton Scott59 | President &CEO | Sell | 83,660 | $0.92 | $77,318.57 | -10.6% | -62.2% | -45.5% | |
| Feb 10, 2025 | MTD Mettler Toledo International Inc/ | Keller Gerry64 | Head Of Process Analytics | Sell | 600 | $1,351.34 | $810,805.68 | -51.0% | -12.4% | +4.5% | |
| Feb 7, 2025 | IMDX Insight Molecular Diagnostics Inc. | Smith Patrick W66 | 10% Owner | Buy | 1,077,600 | $2.05 | $2,209,080.00 | +60.0% | +41.3% | +264.2% | |
| Feb 7, 2025 | IMDX Insight Molecular Diagnostics Inc. | James Andrea S.68 | Chief Financial Officer | Buy | 97,561 | $2.05 | $200,000.05 | +181.8% | +41.3% | +264.2% | |
| Feb 7, 2025 | DHR Danaher Corp /de/ | Spoon Alan G55 | Director | Sell | 550 | $206.46 | $113,553.00 | -0.5% | -5.8% | +4.8% | |
| Feb 7, 2025 | TWST Twist Bioscience Corp | Chess Robert84 | Director | Sell | 2,940 | $53.14 | $156,216.90 | -13.9% | -37.6% | -5.9% | |
| Feb 6, 2025 | IMDX Insight Molecular Diagnostics Inc. | Broadwood Partners, L.P.60 | 10% Owner | Buy | 5,165,695 | $2.05 | $10,589,674.75 | +16.4% | +38.0% | +257.1% | |
| Feb 6, 2025 | RVTY Revvity, Inc. | McMurry-Heath Michelle49 | Director | Sell | 1,970 | $119.49 | $235,395.30 | -39.5% | -23.1% | -14.7% | |
| Feb 6, 2025 | NTRA Natera, Inc. | Fesko John | President, Chief Bus. Officer | Sell | 663 | $177.77 | $117,861.51 | -0.4% | -8.6% | +15.9% | |
| Feb 6, 2025 | NTRA Natera, Inc. | Moshkevich Solomon | President, Clinicaldiagnostics | Sell | 1,632 | $177.77 | $290,120.64 | -1.1% | -8.6% | +15.9% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.